Kevin Slawin

Investing Profile

Sweet spot: $100K Range: $100K–$10M

Rapha Capital Management thesis

Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities Learn More About Rapha Capital The Rapha Capital Mission is to use our unique abilities to identify at the earliest stage, those companies that we believe will go on to profoundly improve peoples’ lives while building great value, from a sea of seemingly indistinguishable, less compelling, opportunities. Rapha Capital Management is focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value. View Our Portfolio Rapha Cap

Sector and stage focus

  • Seed: Pharmaceuticals, BioTech, Consumer Health, Health IT, Health & Hospital Services
  • Series A: Consumer Health, BioTech, Pharmaceuticals, Health IT, Health & Hospital Services
  • general: Raleigh-Durham / Southeast US

Is Kevin Slawin a fit for your round?

Upload your pitch deck and see whether Kevin Slawin appears in your top 20 matches.

Find investors for your deck